Press Releases
Positive CHMP opinion in EU for saxa/dapa (saxagliptin and...
AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion, recommending the approval...
Press Releases
U.S. FDA Approves CSL Behring’s AFSTYL for adults and...
CSL announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® , CSL Behring’s novel long-lasting recombinant factor VIII single-chain therapy for adults...
Press Releases
GSK, Fondazione Telethon and Ospedale San Raffaele announce publication...
GSK, Fondazione Telethon and Ospedale San Raffaeletoday announced the publication in BLOOD of the long-term safety and efficacy data from an analysis of 18 children...
Press Releases
Daiichi Sankyo Launches Antiplatelet Agent Efient® Tablets 20mg
Daiichi Sankyo Company, Limited announced that it has launched the antiplatelet agent Efient® Tablets 20mg  (JAN: Prasugrel Hydrochloride; approval to market: January 20, 2016; NHI...
Press Releases
EISAI To Launch In-House Developed Antiepileptic Drug Fycompa (Perampanel...
Eisai Co Ltd announced that it will launch its in-house-discovered antiepileptic drug (AED) Fycompa® Tablets 2 mg and 4 mg (perampanel hydrate) as an adjunctive...
Press Releases
Novartis highlights its strong foundation for long-term, sustainable growth...
Outlines actions underway to accelerate launch of Entresto®, including further expansion of US primary care field force, and reinforce strong uptake of Cosentyx® Highlights...
Press Releases
FDA Recommends Approval Of Sanofi Treatment For Adults With...
Sanofi announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. FDA recommended the approval of the NDA for the investigational fixed-ratio...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.